title: Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria.
authors.affiliation: Medical Department M, Aarhus University Hospital, Aarhus, Denmark.
authors.forename: Birgitte
authors.initials: B
authors.lastname: Nellemann
authors.forename: Lars C
authors.initials: LC
authors.lastname: Gormsen
authors.forename: Jens
authors.initials: J
authors.lastname: Dollerup
authors.forename: Ole
authors.initials: O
authors.lastname: Schmitz
authors.forename: Carl E
authors.initials: CE
authors.lastname: Mogensen
authors.forename: Lars M
authors.initials: LM
authors.lastname: Rasmussen
authors.forename: Søren
authors.initials: S
authors.lastname: Nielsen
mesh_terms: D000419:Albuminuria / Q000097:blood; D050197:Atherosclerosis / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000652:urine; D003925:Diabetic Angiopathies / Q000517:prevention & control; D003928:Diabetic Nephropathies / Q000097:blood / Q000188:drug therapy; D004311:Double-Blind Method; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D053244:Osteoprotegerin / Q000097:blood*; D019821:Simvastatin / Q000627:therapeutic use*